Clinical Trials Browser

Phase 3 × entecavir × Gastrointestinal × Clear all

NCT06966232 2025-05-11

Prophylactic or Preemptive Entecavir in Patients With Gastrointestinal Cancer Who Are Inactive Hepatitis B Carriers

Phase 3 Recruiting

Gastrointestinal

Gastrointestinal Neoplasms

NCT02650271 2024-01-23

Adjuvant Entecavir or Tenofovir for Postoperative HBV-HCC

Phase 3 Completed

Gastrointestinal

Carcinoma, Hepatocellular

NCT04392700 2020-05-19

A RCT of TNF and ENT in the Treatment of Long-term Prognosis With Hepatitis B-related HCC After Curative Resection

Phase 3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular